Since the introduction of liver therapy in the treatment of pernicious anaemia many attempts have been made to produce an active extract which may be given parenterally in small doses without any undesirable side effects. One of the more recent preparations is that of Gannslen of Tubingen which is commercially obtainable in this country. The following is a report on the results of its administration to five patientsthree patients with severe pernicious anaemia, one case of sprue, and one case of anaemia associated with the haemorrhagic diathesis.
The extract, the commercial name of which is Campolon, is given intramuscularly once daily in a dose of 2 c.c. The extract is so active that this represents only 5 
